Cited by 101Growth Hormone and Insulin-like Growth FactorsPancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Acute Metabolic Effects of Human Growth Hormone

Fineberg, S Edwin, Merimee, Thomas J·1974·Diabetes

Abstract

These studies were done to clarify the actions of human growth hormone (HGH) during the two hours after concentrations were increased. These effects cannot be attributed to generation of somatomedin. Mean systemic levels of HGH were increased to 92.6 ng. per milliliter by the intravenous infusion of 4 mg. of HGH over thirty minutes. During the first hour, mean plasma glucose and free fatty acid (FFA) concentrations decreased by 9.5 ± 1.9 per cent and 21.2 ± 3.6 per cent, respectively. After two hours, FFA concentrations rose to 145 per cent of basal. An identical preparation of HGH was then perfused across forearm tissues at mean forearm venous concentrations of 28.4 ± 1.5 ng. per milliliter or 200.3 ± 7.9 ng. per milliliter. Glucose uptake was acutely decreased (by 30 per cent) by both doses of HGH; neither dose had significant effects upon lipolysis. Therefore, neither physiologic nor supraphysiologic concentrations of HGH had an insulin-like effect upon peripheral muscle or adipose tissue. Small increases in peripheral HGH concentrations had virtually identical effects upon enhancement of potassium uptake and reduction of glucose uptake across muscle as mean concentrations ten times higher.

Integrity signals

Registry

Crossref · 10.2337/diab.23.6.499

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cited by

Sorted by citations

Authors
Fineberg, S. E., & Merimee, T. J.
Affiliations
Boston University (US)
Venue
Diabetes
Published
1974-06-01
Volume
23
Issue
6
Pages
499-504
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2160436622
Cited by
101
References
0
Citations by year
2025: 1 · 2023: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2016: 1 · 2015: 2 · 2014: 2 · 2013: 3 · 2012: 1
FWCI
1.45
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Funders
NIH Clinical Center
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
human growth hormone, plasma glucose, free fatty acids, glucose uptake, lipolysis, insulin-like activity, insulin-like growth factor, muscle, adipose tissue, potassium uptake, hyperinsulinemic-euglycemic clamp
MeSH terms
Adipose Tissue, Adult, Arteries, Blood Flow Velocity, Blood Glucose, Fasting, Fatty Acids, Nonesterified, Female, Forearm, Humans, Injections, Intra-Arterial, Injections, Intravenous, Male, Perfusion, Potassium, Growth Hormone, Time Factors, Veins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review